Maternal plasma procalcitonin concentrations in pregnancy complicated by preterm premature rupture of membranes.
OBJECTIVE
Our objective is to compare maternal plasma procalcitonin concentrations in preterm premature rupture of membranes (pPROM) and premature rupture of membranes (PROM) at term with their levels in uncomplicated pregnancy, and to determine whether these concentrations are useful in the diagnosis of pPROM cases suspected of infection and in the prediction of pPROM-to-delivery interval.


METHODS
Forty eight patients with pPROM, 30 with PROM at term, 31 healthy women at preterm gestation, and 33 healthy women at term were included. In pPROM group, analysis of procalcitonin concentrations with reference to leucocytosis, serum C-reactive protein, vaginal fluid culture, neonatal infection, histological chorioamnionitis and pPROM-to-delivery interval was carried out.


RESULTS
Procalcitonin concentrations in pPROM and PROM at term cases were comparable. However, in both groups procalcitonin values were significantly higher than in healthy controls in approximate gestational age. In pPROM group, procalcitonin concentrations between the patients with and without laboratory indices of infection were comparable, as well as between patients who gave birth to newborns with and without congenital infection, and between patients with and without histological chorioamnionitis. The predictive values of procalcitonin determinations were poor.


CONCLUSIONS
The value of maternal plasma procalcitonin determinations in the diagnostics of pPROM cases suspected of intraamniotic infection, as well as for the prediction of pPROM-to-delivery interval, newborn's infection or histological chorioamnionitis is unsatisfactory. However, procalcitonin concentrations are elevated, both in patients with preterm and term PROMs in comparison to healthy pregnants, and therefore further evaluations are necessary to establish the role of procalcitonin in the pathophysiology of pregnancy.
Torbé
Andrzej
A
Department of Obstetrics and Gynecology, Pomeranian Medical University, Al. Powstańców Wielkopolskich 72, 70-111 Szczecin, Poland.
D000328:Adult; D002116:Calcitonin / Q000097:blood*; D015740:Calcitonin Gene-Related Peptide; D036861:Delivery, Obstetric; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000097:blood*; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D007752:Obstetric Labor, Premature / Q000097:blood; D011247:Pregnancy; D011498:Protein Precursors / Q000097:blood*
C000606589:CALCA protein, human; D011498:Protein Precursors; D002116:Calcitonin; D015740:Calcitonin Gene-Related Peptide
J Med Assoc Thai. 2001 Jun;84 Suppl 1:S360-6
11529358
Clin Chim Acta. 2002 Sep;323(1-2):17-29
12135804
Horm Metab Res. 2002 Aug;34(8):460-5
12198603
J Perinat Med. 2002;30(6):480-2
12530104
Ginekol Pol. 2003 Oct;74(10):1037-43
14669391
MCN Am J Matern Child Nurs. 2004 May-Jun;29(3):144-50
15123969
J Perinat Med. 2004;32(4):332-6
15346819
Eur J Obstet Gynecol Reprod Biol. 2004 Oct 15;116(2):177-81
15358460
Lancet. 1993 Feb 27;341(8844):515-8
8094770
Obstet Gynecol. 1995 May;85(5 Pt 1):766-8
7724110
Am J Obstet Gynecol. 1996 Oct;175(4 Pt 1):966-9
8885756
J Perinat Med. 1996;24(6):563-72
9120739
Eur J Med Res. 1996 Apr 18;1(7):331-3
9364034
South Med J. 1997 Dec;90(12):1229-33
9404911
Am J Obstet Gynecol. 1998 Dec;179(6 Pt 1):1599-604
9855604
Infection. 1999 Jan-Feb;27(1):34-5
10027104
J Perinat Med. 1998;26(6):491-4
10224608
BJOG. 2007 Feb;114(2):143-7
17305891
Acta Obstet Gynecol Scand. 2000 Aug;79(8):667-72
10949232
Int J Gynaecol Obstet. 2000 Nov;71(2):107-11
11064006